Nkarta (NKTX) Other Non Operating Income (2019 - 2026)
Nkarta's quarterly Other Non Operating Income came in at $206000.0 in Q1 2026, little changed year-on-year from $205000.0 in Q1 2025, and down 19.53% quarter-over-quarter from $256000.0 in Q4 2025.
Nkarta has reported Other Non Operating Income for 8 years, with the latest figure at $206000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income changed 0.49% year-over-year to $206000.0; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (up 723.13% YoY), and the FY2025 full-year result was $2.4 million, up 2680.46% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $206000.0, down from $256000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $1.7 million in Q3 2025, with the low at -$489000.0 in Q4 2022.
- Average Other Non Operating Income over 5 years is $134352.9, with a median of $17000.0 recorded in 2022.
- Year-over-year, Other Non Operating Income slumped 24350.0% in 2022 and jumped 57400.0% in 2025.
- Tracing NKTX's Other Non Operating Income over 5 years: stood at -$489000.0 in 2022, then soared by 94.89% to -$25000.0 in 2023, then soared by 476.0% to $94000.0 in 2024, then soared by 172.34% to $256000.0 in 2025, then retreated by 19.53% to $206000.0 in 2026.
- The last three Other Non Operating Income figures came in at $206000.0 (Q1 2026), $256000.0 (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Nkarta | 232.80 Mn | 232.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 206,000.00 |
| Dec 31, 2025 | 256,000.00 |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 239,000.00 |
| Mar 31, 2025 | 205,000.00 |
| Dec 31, 2024 | 94,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | -25,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 33,000.00 |
| Dec 31, 2022 | -489,000.00 |
| Sep 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -6,000.00 |
| Jun 30, 2021 | -5,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Dec 31, 2020 | 146,000.00 |
| Sep 30, 2020 | -153,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Dec 31, 2019 | -787,000.00 |
| Sep 30, 2019 | 35,000.00 |